Guillain-Barré syndrome is immunogenic in SARS-CoV-2 infected.

Finsterer, Josef; Almas, Talal

Finsterer, Josef; Almas, Talal.

Finsterer J; Klinik Landstrasse, Messerli Institute, Vienna, Austria.
Almas T; RCSI University of Medicine and Health Sciences, Dublin, Ireland.

J Med Virol ; 94(1): 22-23, 2022 01.

Article in English | MEDLINE | ID: covidwho-1513862

Subject(s)

COVID-19/pathology; Guillain-Barre Syndrome/immunology; Guillain-Barre Syndrome/pathology; Humans; Interleukin-6/blood; Interleukin-6/cerebrospinal fluid; Interleukin-8/blood; Interleukin-8/cerebrospinal fluid; RNA, Viral/analysis; SARS-CoV-2/immunology

Keywords

COVID-19; SARS-CoV-2; neuropathy; polyradiculitis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Limits: Humans Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27314

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google